These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9537693)

  • 1. Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features.
    Kinoshita H; Ogawa O; Mishina M; Oka H; Okumura K; Yamabe H; Terachi T; Yoshida O
    Urol Res; 1998; 26(1):29-32. PubMed ID: 9537693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of telomerase activity in malignant pheochromocytoma.
    Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
    Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues.
    Isobe K; Yashiro T; Omura S; Kaneko M; Kaneko S; Kamma H; Tatsuno I; Takekoshi K; Kawakami Y; Nakai T
    Endocr J; 2004 Feb; 51(1):47-52. PubMed ID: 15004408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in benign and malignant adrenal tumors.
    Bamberger CM; Else T; Bamberger AM; Frilling A; Beil FU; Allolio B; Schulte HM
    Exp Clin Endocrinol Diabetes; 1999; 107(4):272-5. PubMed ID: 10433067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of cyclooxygenase-2 in malignant pheochromocytomas.
    Salmenkivi K; Haglund C; Ristimäki A; Arola J; Heikkilä P
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5615-9. PubMed ID: 11701743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
    Sangoi AR; McKenney JK
    Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma.
    Boltze C; Mundschenk J; Unger N; Schneider-Stock R; Peters B; Mawrin C; Hoang-Vu C; Roessner A; Lehnert H
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4280-6. PubMed ID: 12970299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance.
    Kanauchi H; Wada N; Clark OH; Duh QY
    Surgery; 2002 Dec; 132(6):1021-6; discussion 1026-7. PubMed ID: 12490850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
    Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
    Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of human telomerase catalytic subunit mRNA by in situ hybridization in pheochromocytomas.
    Luo Z; Li J; Qin Y; Ma Y; Liang X; Xian J; Lu D; Wei M; Yang JY; Yang MQ; He Z
    Endocr Pathol; 2006; 17(4):387-98. PubMed ID: 17525487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pheochromocytomas in adrenal medulla or extra-adrenal and multiple endocrine neoplasms:a clinicopathologic analysis of 181 cases].
    Jiang CX; Zeng Z; Wang T; Liu X; Liu R; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):762-6. PubMed ID: 22336161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors.
    Ramsay JA; Asa SL; van Nostrand AW; Hassaram ST; de Harven EP
    Am J Surg Pathol; 1987 Jun; 11(6):480-6. PubMed ID: 3592062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity as an indicator of potentially malignant adrenal tumors.
    Hirano Y; Fujita K; Suzuki K; Ushiyama T; Ohtawara Y; Tsuda F
    Cancer; 1998 Aug; 83(4):772-6. PubMed ID: 9708944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase in endocrine and endocrine-dependent tumors.
    Orlando C; Gelmini S
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):201-14. PubMed ID: 11595501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in the differentiation of benign and malignant adrenal tumors.
    Teng L; Tucker O; Malchoff C; Vaughan ED; Jacobson J; Fahey TJ
    Surgery; 1998 Dec; 124(6):1123-7. PubMed ID: 9854593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential heparanase-1 expression in malignant and benign pheochromocytomas.
    Quiros RM; Kim AW; Maxhimer J; Gattuso P; Xu X; Prinz RA
    J Surg Res; 2002 Nov; 108(1):44-50. PubMed ID: 12443714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid enzyme activities in extraadrenal pheochromocytomas.
    Carballeira A; Fishman LM
    J Clin Endocrinol Metab; 1982 Mar; 54(3):619-24. PubMed ID: 7056845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic adrenal neoplasms.
    Erickson LA; Lloyd RV; Hartman R; Thompson G
    Cancer; 2004 Oct; 101(7):1537-44. PubMed ID: 15378490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cushing's syndrome in unilateral diffuse-nodular hyperplasia of the adrenal cortex with a corticosteroma and in combination with a pheochromocytoma].
    Bronshteĭn ME; Tsitsiashvili BSh; Kolesnikova GS; Rozhinskaia LIa; Kesh'ian RG
    Probl Endokrinol (Mosk); 1989; 35(4):46-50. PubMed ID: 2557610
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
    Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
    Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.